R1	Has_temporal Arg1:T6 Arg2:T7	
R2	Has_index Arg1:T7 Arg2:T8	
R3	Has_mood Arg1:T12 Arg2:T11	
R4	Has_temporal Arg1:T11 Arg2:T9	
R5	Has_index Arg1:T9 Arg2:T10	
R6	Has_index Arg1:T15 Arg2:T16	
R7	Has_temporal Arg1:T14 Arg2:T15	
*	OR T18 T19
R8	Has_index Arg1:T20 Arg2:T21	
R9	Has_temporal Arg1:T18 Arg2:T20	
R10	Has_index Arg1:T25 Arg2:T26	
R11	Has_index Arg1:T27 Arg2:T28	
R12	Has_temporal Arg1:T24 Arg2:T25	
R13	AND Arg1:T23 Arg2:T24	
R14	AND Arg1:T30 Arg2:T31	
R15	AND Arg1:T30 Arg2:T32	
*	OR T33 T34 T35
R16	Has_temporal Arg1:T33 Arg2:T36	
R17	Has_multiplier Arg1:T44 Arg2:T45	
R18	Has_temporal Arg1:T46 Arg2:T47	
R19	Has_temporal Arg1:T46 Arg2:T48	
R20	Subsumes Arg1:T44 Arg2:T46	
*	OR T41 T42
R21	Subsumes Arg1:T40 Arg2:T41	
R22	Has_temporal Arg1:T40 Arg2:T43	
*	OR T51 T50
*	OR T39 T38
R23	Has_context Arg1:T39 Arg2:T51	
*	OR T39 T40 T44
R24	AND Arg1:T54 Arg2:T55	
R25	AND Arg1:T54 Arg2:T56	
R26	Has_value Arg1:T55 Arg2:T57	
R27	Has_value Arg1:T56 Arg2:T57	
R28	AND Arg1:T60 Arg2:T61	
R29	AND Arg1:T63 Arg2:T64	
R30	Has_qualifier Arg1:T64 Arg2:T66	
R31	AND Arg1:T70 Arg2:T71	
R32	Subsumes Arg1:T69 Arg2:T70	
R33	Has_index Arg1:T74 Arg2:T75	
R35	Subsumes Arg1:T76 Arg2:T77	
*	OR T72 T73
R34	Has_temporal Arg1:T72 Arg2:T74	
R36	Has_qualifier Arg1:T80 Arg2:T81	
*	OR T79 T82
R37	Has_index Arg1:T90 Arg2:T91	
R38	Has_value Arg1:T93 Arg2:T94	
R39	Subsumes Arg1:T92 Arg2:T93	
*	OR T87 T88
*	OR T85 T86
R40	Has_qualifier Arg1:T87 Arg2:T85	
R41	Has_temporal Arg1:T87 Arg2:T90	
R42	Has_temporal Arg1:T92 Arg2:T90	
R43	AND Arg1:T84 Arg2:T92	
R44	Has_index Arg1:T100 Arg2:T101	
R45	Has_value Arg1:T103 Arg2:T104	
R46	Subsumes Arg1:T102 Arg2:T103	
R47	Has_temporal Arg1:T99 Arg2:T100	
R48	AND Arg1:T98 Arg2:T99	
*	OR T110 T109
R49	Has_index Arg1:T112 Arg2:T113	
R50	Has_temporal Arg1:T108 Arg2:T112	
R51	Has_qualifier Arg1:T108 Arg2:T110	
R52	Has_temporal Arg1:T115 Arg2:T116	
R53	Has_index Arg1:T1 Arg2:T2	
R54	Has_temporal Arg1:T24 Arg2:T27	
R55	AND Arg1:T98 Arg2:T102	
T1	Temporal 21 48	4 weeks preceding inclusion
T2	Reference_point 39 48	inclusion
T3	Mood 52 73	planned participation
T4	Context_Error 0 200	Participation in the 4 weeks preceding inclusion or planned participation during the present trial period in another clinical trial investigating a vaccine, drug, medical device, or medical procedure.
T5	Post-eligibility 0 200	Participation in the 4 weeks preceding inclusion or planned participation during the present trial period in another clinical trial investigating a vaccine, drug, medical device, or medical procedure.
T6	Drug 217 224	vaccine
T7	Temporal 225 272	in the 4 weeks preceding each trial vaccination
T8	Reference_point 250 272	each trial vaccination
T9	Temporal 307 354	in the 4 weeks following each trial vaccination
T10	Reference_point 332 354	each trial vaccination
T11	Mood 276 291	planned receipt
T12	Drug 299 306	vaccine
T13	Parsing_Error 356 367	except for:
T14	Drug 373 394	influenza vaccination
T15	Temporal 418 456	at least 2 weeks before study vaccines
T16	Reference_point 442 456	study vaccines
T17	Negation 356 366	except for
T18	Procedure 464 475;517 528	measles (M) vaccination
T19	Procedure 479 508;517 528	measles, mumps, rubella (MMR) vaccination
T20	Temporal 556 606	concomitantly with the first dose of study vaccine
T21	Reference_point 575 606	the first dose of study vaccine
T23	Visit 676 688	Indian sites
T24	Drug 690 722	oral poliomyelitis vaccine (OPV)
T25	Temporal 732 772	during National Immunization Days (NIDs)
T26	Reference_point 739 772	National Immunization Days (NIDs)
T27	Temporal 732 738;777 825	during supplementary immunization activity days (SIADs)
T28	Reference_point 777 825	supplementary immunization activity days (SIADs)
T30	Procedure 836 877	vaccination against meningococcal disease
T31	Drug 894 907	study vaccine
T32	Drug 911 940	another meningococcal vaccine
T33	Drug 953 969	immune globulins
T34	Drug 971 976	blood
T35	Drug 980 1002	blood-derived products
T36	Temporal 1003 1023	in the past 3 months
T38	Condition 1058 1083	acquired immunodeficiency
T39	Condition 1044 1054;1067 1083	congenital immunodeficiency
T40	Procedure 1099 1124	immunosuppressive therapy
T41	Procedure 1134 1158	anti-cancer chemotherapy
T42	Procedure 1162 1179	radiation therapy
T43	Temporal 1181 1210	within the preceding 6 months
T44	Procedure 1225 1256	systemic corticosteroid therapy
T45	Multiplier 1215 1224	long-term
T46	Drug 1258 1268	prednisone
T47	Temporal 1283 1316	for more than 2 consecutive weeks
T48	Temporal 1317 1341	within the past 3 months
T50	Observation 1034 1043	suspected
T51	Observation 1025 1030	Known
T54	Condition 1355 1377	meningococcal diseases
T55	Procedure 1408 1421	serologically
T56	Procedure 1426 1443	microbiologically
T57	Value 1379 1388	confirmed
T58	Non-query-able 1445 1537	At high risk, in the opinion of the Investigator, for meningococcal disease during the trial
T59	Subjective_judgement 1445 1537	At high risk, in the opinion of the Investigator, for meningococcal disease during the trial
T60	Condition 1558 1583	systemic hypersensitivity
T61	Drug 1598 1616	vaccine components
T62	Temporal 1621 1628	history
T63	Condition 1634 1659	life-threatening reaction
T64	Drug 1667 1674	vaccine
T65	Drug 1701 1708	vaccine
T66	Qualifier 1675 1692	used in the trial
T67	Context_Error 1675 1692	used in the trial
T68	Context_Error 1539 1746	Known or suspected systemic hypersensitivity to any of the vaccine components, or history of a life-threatening reaction to the vaccine used in the trial or to a vaccine containing any of the same substances
T69	Condition 1754 1770	thrombocytopenia
T70	Condition 1772 1788	contraindicating
T71	Procedure 1789 1814	intramuscular vaccination
T72	Condition 1816 1833	Bleeding disorder
T73	Drug 1849 1863	anticoagulants
T74	Temporal 1864 1898	in the 3 weeks preceding inclusion
T75	Reference_point 1889 1898	inclusion
T76	Condition 1900 1916	contraindicating
T77	Procedure 1917 1942	intramuscular vaccination
T79	Visit 1950 1967	emergency setting
T80	Procedure 1972 1984	hospitalized
T81	Qualifier 1985 1998	involuntarily
T82	Condition 1972 1998	hospitalized involuntarily
T83	Subjective_judgement 2000 2129	Chronic illness that, in the opinion of the investigator, is at a stage where it might interfere with trial conduct or completion
T84	Visit 2156 2168	Indian sites
T85	Qualifier 2170 2178	Moderate
T86	Qualifier 2182 2188	severe
T87	Condition 2189 2202	acute illness
T88	Condition 2189 2194;2203 2212	acute infection
T89	Subjective_judgement 2214 2248	according to investigator judgment
T90	Temporal 2250 2275	on the day of vaccination
T91	Reference_point 2253 2275	the day of vaccination
T92	Condition 2279 2294	febrile illness
T93	Measurement 2296 2307	temperature
T94	Value 2308 2316	≥ 38.0°C
T98	Visit 2345 2358	Russian sites
T99	Condition 2360 2373	Acute disease
T100	Temporal 2390 2415	on the day of vaccination
T101	Reference_point 2393 2415	the day of vaccination
T102	Condition 2419 2434	febrile illness
T103	Measurement 2436 2456	axillary temperature
T104	Value 2457 2465	≥ 37.0°C
T106	Non-query-able 2469 2594	A prospective subject should not be included in the study until the condition has resolved or the febrile event has subsided.
T107	Not_a_criteria 2469 2594	A prospective subject should not be included in the study until the condition has resolved or the febrile event has subsided.
T108	Drug 2626 2644	antibiotic therapy
T109	Qualifier 2615 2625	injectable
T110	Qualifier 2607 2611	oral
T112	Temporal 2645 2690	within 72 hours prior to the first blood draw
T113	Reference_point 2670 2690	the first blood draw
T114	Non-query-able 2692 2810	Identified as a natural or adopted child of the Investigator or employee with direct involvement in the proposed study
T115	Condition 2832 2855	Guillain-Barré Syndrome
T116	Temporal 2821 2828	history
